BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 38377146)

  • 1. TRPS1 modulates chromatin accessibility to regulate estrogen receptor alpha (ER) binding and ER target gene expression in luminal breast cancer cells.
    Scott TG; Sathyan KM; Gioeli D; Guertin MJ
    PLoS Genet; 2024 Feb; 20(2):e1011159. PubMed ID: 38377146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRPS1 modulates chromatin accessibility to regulate estrogen receptor (ER) binding and ER target gene expression in luminal breast cancer cells.
    Scott TG; Sathyan KM; Gioeli D; Guertin MJ
    bioRxiv; 2023 Jul; ():. PubMed ID: 37461612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear cathepsin D enhances TRPS1 transcriptional repressor function to regulate cell cycle progression and transformation in human breast cancer cells.
    Bach AS; Derocq D; Laurent-Matha V; Montcourrier P; Sebti S; Orsetti B; Theillet C; Gongora C; Pattingre S; Ibing E; Roger P; Linares LK; Reinheckel T; Meurice G; Kaiser FJ; Gespach C; Liaudet-Coopman E
    Oncotarget; 2015 Sep; 6(29):28084-103. PubMed ID: 26183398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRPS1 regulates oestrogen receptor binding and histone acetylation at enhancers.
    Serandour AA; Mohammed H; Miremadi A; Mulder KW; Carroll JS
    Oncogene; 2018 Sep; 37(39):5281-5291. PubMed ID: 29895970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer.
    Ai D; Yao J; Yang F; Huo L; Chen H; Lu W; Soto LMS; Jiang M; Raso MG; Wang S; Bell D; Liu J; Wang H; Tan D; Torres-Cabala C; Gan Q; Wu Y; Albarracin C; Hung MC; Meric-Bernstam F; Wistuba II; Prieto VG; Sahin AA; Ding Q
    Mod Pathol; 2021 Apr; 34(4):710-719. PubMed ID: 33011748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A central role for TRPS1 in the control of cell cycle and cancer development.
    Wu L; Wang Y; Liu Y; Yu S; Xie H; Shi X; Qin S; Ma F; Tan TZ; Thiery JP; Chen L
    Oncotarget; 2014 Sep; 5(17):7677-90. PubMed ID: 25277197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical GATA transcription factor TRPS1 represses gene expression by recruiting CHD4/NuRD(MTA2) and suppresses cell migration and invasion by repressing TP63 expression.
    Wang Y; Lin X; Gong X; Wu L; Zhang J; Liu W; Li J; Chen L
    Oncogenesis; 2018 Dec; 7(12):96. PubMed ID: 30563971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXA1 represses the molecular phenotype of basal breast cancer cells.
    Bernardo GM; Bebek G; Ginther CL; Sizemore ST; Lozada KL; Miedler JD; Anderson LA; Godwin AK; Abdul-Karim FW; Slamon DJ; Keri RA
    Oncogene; 2013 Jan; 32(5):554-63. PubMed ID: 22391567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of TRPS1 gene with different EMT markers in ERα-positive and ERα-negative breast cancer.
    Su P; Hu J; Zhang H; Jia M; Li W; Jing X; Zhou G
    Diagn Pathol; 2014 Jun; 9():119. PubMed ID: 24934762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PARP-1 Regulates Estrogen-Dependent Gene Expression in Estrogen Receptor α-Positive Breast Cancer Cells.
    Gadad SS; Camacho CV; Malladi V; Hutti CR; Nagari A; Kraus WL
    Mol Cancer Res; 2021 Oct; 19(10):1688-1698. PubMed ID: 34158394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells.
    Elster D; Tollot M; Schlegelmilch K; Ori A; Rosenwald A; Sahai E; von Eyss B
    Nat Commun; 2018 Aug; 9(1):3115. PubMed ID: 30082728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the GATA factor TRPS1 as a repressor of the osteocalcin promoter.
    Piscopo DM; Johansen EB; Derynck R
    J Biol Chem; 2009 Nov; 284(46):31690-703. PubMed ID: 19759027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. During hormone depletion or tamoxifen treatment of breast cancer cells the estrogen receptor apoprotein supports cell cycling through the retinoic acid receptor α1 apoprotein.
    Salazar MD; Ratnam M; Patki M; Kisovic I; Trumbly R; Iman M; Ratnam M
    Breast Cancer Res; 2011 Feb; 13(1):R18. PubMed ID: 21299862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of TRPS1 stimulates epithelial-mesenchymal transition and metastasis through repression of FOXA1.
    Huang JZ; Chen M; Zeng M; Xu SH; Zou FY; Chen D; Yan GR
    J Pathol; 2016 Jun; 239(2):186-96. PubMed ID: 26969828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ELF5 suppresses estrogen sensitivity and underpins the acquisition of antiestrogen resistance in luminal breast cancer.
    Kalyuga M; Gallego-Ortega D; Lee HJ; Roden DL; Cowley MJ; Caldon CE; Stone A; Allerdice SL; Valdes-Mora F; Launchbury R; Statham AL; Armstrong N; Alles MC; Young A; Egger A; Au W; Piggin CL; Evans CJ; Ledger A; Brummer T; Oakes SR; Kaplan W; Gee JM; Nicholson RI; Sutherland RL; Swarbrick A; Naylor MJ; Clark SJ; Carroll JS; Ormandy CJ
    PLoS Biol; 2012; 10(12):e1001461. PubMed ID: 23300383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRPS1 acts as a context-dependent regulator of mammary epithelial cell growth/differentiation and breast cancer development.
    Cornelissen LM; Drenth AP; van der Burg E; de Bruijn R; Pritchard CEJ; Huijbers IJ; Zwart W; Jonkers J
    Genes Dev; 2020 Feb; 34(3-4):179-193. PubMed ID: 31879358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GATA3 and TRPS1 are distinct biomarkers and prognostic factors in breast cancer: database mining for GATA family members in malignancies.
    Lin HY; Zeng D; Liang YK; Wei XL; Chen CF
    Oncotarget; 2017 May; 8(21):34750-34761. PubMed ID: 28423734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional repressor GATA binding 1-mediated repression of SRY-box 2 expression suppresses cancer stem cell functions and tumor initiation.
    Gong X; Liu W; Wu L; Ma Z; Wang Y; Yu S; Zhang J; Xie H; Wei G; Ma F; Lu L; Chen L
    J Biol Chem; 2018 Nov; 293(48):18646-18654. PubMed ID: 30315105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ARID1A-dependent permissive chromatin accessibility licenses estrogen-receptor signaling to regulate circadian rhythms genes in endometrial cancer.
    Hu H; Chen Z; Ji L; Wang Y; Yang M; Lai R; Zhong Y; Zhang X; Wang L
    Cancer Lett; 2020 Nov; 492():162-173. PubMed ID: 32858102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trichorhinophalangeal syndrome type 1 (TRPS1) expression in male breast carcinoma.
    Law T; Piotrowski MJ; Ning J; Jiang X; Ding Q; Sahin AA
    Hum Pathol; 2023 Aug; 138():62-67. PubMed ID: 37331526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.